Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpeBio is a biotechnology company specializing in the development and manufacture of high-quality reagents and diagnostic solutions for the global life sciences industry. Headquartered in Santa Clara, California, with significant operations in Shanghai, the company provides a comprehensive catalog of products including recombinant proteins, monoclonal and polyclonal antibodies, and ELISA kits. These tools support critical research in oncology, immunology, and infectious diseases, and the company gained significant visibility for its diagnostic solutions during the COVID-19 pandemic. In addition to its product portfolio, SpeBio offers contract research services (CRO) such as custom protein expression and antibody production to support pharmaceutical and academic R&D. The company serves a diverse client base ranging from global pharmaceutical firms to academic research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpeBio.